Xenon Pharmaceuticals Inc. SEC filings XENE
Xenon Pharmaceuticals Inc. has 800 filings in SEC EDGAR's recent list, going back to Aug 16, 2013. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 POS | Filing | Jun 3, 2026 | — |
| S-8 | Employee stock plan registration | Jun 3, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 3, 2026 | Jun 2, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 22, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEF 14A | Proxy statement | Apr 22, 2026 | Apr 22, 2026 |
| S-8 | Employee stock plan registration | Apr 13, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Apr 13, 2026 | Apr 7, 2026 |
| 8-K |
Current report
Other events
|
Mar 13, 2026 | Mar 13, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 12, 2026 | Mar 10, 2026 |
| 424B5 | Prospectus supplement | Mar 12, 2026 | — |
| FWP | Free writing prospectus | Mar 11, 2026 | — |
| 424B5 | Prospectus supplement | Mar 9, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 9, 2026 | Mar 9, 2026 |
| 8-K |
Current report
Other events
|
Feb 27, 2026 | Feb 27, 2026 |
| 424B5 | Prospectus supplement | Feb 27, 2026 | — |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 26, 2026 | Feb 26, 2026 |
| S-8 | Employee stock plan registration | Dec 1, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Dec 1, 2025 | Nov 24, 2025 |
| 10-Q | Quarterly report | Nov 3, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 3, 2025 | Nov 3, 2025 |
| 8-K/A |
Amended current report
Officer or director change, Other events
|
Oct 17, 2025 | Oct 15, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 16, 2025 | Oct 15, 2025 |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 3, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2025 | Jun 4, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2025 | May 12, 2025 |
| ARS | Annual report to shareholders | Apr 24, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 24, 2025 | — |
| DEF 14A | Proxy statement | Apr 24, 2025 | Apr 24, 2025 |
| 8-K |
Current report
Other events
|
Mar 17, 2025 | Mar 14, 2025 |
| 8-K |
Current report
Auditor change
|
Mar 5, 2025 | Mar 3, 2025 |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Feb 27, 2025 | Feb 24, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 17, 2025 | Jan 17, 2025 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 12, 2024 | Nov 12, 2024 |
| S-3ASR | Automatic shelf registration | Aug 9, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2024 | Aug 8, 2024 |
| S-8 | Employee stock plan registration | Jun 5, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2024 | Jun 4, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 26, 2024 | Apr 26, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 19, 2024 | Apr 15, 2024 |
| 8-K |
Current report
Other events
|
Mar 8, 2024 | Mar 8, 2024 |
| 10-K | Annual report | Feb 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 29, 2024 | Feb 29, 2024 |
| 424B5 | Prospectus supplement | Nov 30, 2023 | — |
| 8-K |
Current report
Material agreement, Other events
|
Nov 30, 2023 | Nov 29, 2023 |
| 424B5 | Prospectus supplement | Nov 29, 2023 | — |
| 8-K |
Current report
Other events
|
Nov 27, 2023 | Nov 27, 2023 |
| 8-K |
Current report
Other events
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 8, 2023 | Nov 8, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Acquisition or sale of assets, Regulation FD disclosure
|
Aug 9, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2023 | Jun 1, 2023 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 9, 2023 | May 9, 2023 |
| ARS | Annual report to shareholders | Apr 27, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Apr 27, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Mar 14, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Other events
|
Mar 8, 2023 | Mar 8, 2023 |
| 10-K | Annual report | Mar 1, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 1, 2023 | Mar 1, 2023 |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Other events
|
Nov 7, 2022 | Nov 7, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 424B5 | Prospectus supplement | Jun 23, 2022 | — |
| 8-K |
Current report
Other events
|
Jun 23, 2022 | Jun 22, 2022 |
| 424B5 | Prospectus supplement | Jun 22, 2022 | — |
| 8-K |
Current report
Other events
|
Jun 21, 2022 | Jun 21, 2022 |
| S-8 | Employee stock plan registration | Jun 2, 2022 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 2, 2022 | Jun 1, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| DEF 14A | Proxy statement | Apr 28, 2022 | Jun 1, 2022 |
| 8-K |
Current report
Unregistered share sale
|
Mar 22, 2022 | Mar 16, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 10, 2022 | Mar 9, 2022 |
| 424B5 | Prospectus supplement | Mar 1, 2022 | — |
| 8-K |
Current report
Material agreement
|
Mar 1, 2022 | Mar 1, 2022 |
| 10-K | Annual report | Mar 1, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 1, 2022 | Mar 1, 2022 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Jan 12, 2022 | Jan 11, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 1, 2021 | Nov 24, 2021 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 424B5 | Prospectus supplement | Oct 6, 2021 | — |
| 8-K |
Current report
Other events
|
Oct 6, 2021 | Oct 5, 2021 |
| FWP | Free writing prospectus | Oct 5, 2021 | — |
| 424B5 | Prospectus supplement | Oct 4, 2021 | — |
| S-3ASR | Automatic shelf registration | Oct 4, 2021 | — |
| 8-K |
Current report
Other events
|
Oct 4, 2021 | Oct 4, 2021 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Sep 8, 2021 | Sep 8, 2021 |
| 8-K |
Current report
Other events
|
Aug 23, 2021 | Aug 23, 2021 |
| 10-Q | Quarterly report | Aug 11, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2021 | Aug 11, 2021 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 3, 2021 | Jun 3, 2021 |
| 10-Q | Quarterly report | May 11, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 11, 2021 | May 11, 2021 |
| DEF 14A | Proxy statement | Apr 28, 2021 | Jun 3, 2021 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 12, 2021 | Mar 12, 2021 |
| 424B5 | Prospectus supplement | Mar 10, 2021 | — |
| 8-K |
Current report
Other events
|
Mar 10, 2021 | Mar 9, 2021 |
| 424B5 | Prospectus supplement | Mar 9, 2021 | — |
| 10-K | Annual report | Mar 1, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Mar 1, 2021 | Feb 23, 2021 |
| 8-K/A |
Amended current report
Officer or director change
|
Jan 14, 2021 | Nov 3, 2020 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Jan 14, 2021 | Jan 12, 2021 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 5, 2020 | Nov 3, 2020 |
| CT ORDER | Filing | Sep 1, 2020 | — |
| 8-K |
Current report
Other events
|
Aug 17, 2020 | Aug 17, 2020 |
| 424B5 | Prospectus supplement | Aug 6, 2020 | — |
| 8-K |
Current report
Material agreement
|
Aug 6, 2020 | Aug 6, 2020 |
| 10-Q | Quarterly report | Aug 6, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2020 | Aug 6, 2020 |
| EFFECT | Filing | Jun 12, 2020 | — |
| CORRESP | Letter to the SEC | Jun 10, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2020 | — |
| S-3 | Shelf registration | Jun 3, 2020 | — |
| S-8 | Employee stock plan registration | Jun 3, 2020 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 3, 2020 | Jun 1, 2020 |
| 10-Q/A | Amended quarterly report | May 26, 2020 | Mar 31, 2020 |
| 10-Q/A | Amended quarterly report | May 22, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | May 21, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 21, 2020 | May 21, 2020 |
| 8-K |
Current report
Other events
|
May 6, 2020 | May 6, 2020 |
| DEF 14A | Proxy statement | Apr 28, 2020 | Jun 1, 2020 |
| 8-K |
Current report
Officer or director change
|
Mar 13, 2020 | Mar 12, 2020 |
| 8-K |
Current report
Other events
|
Mar 11, 2020 | Mar 11, 2020 |
| S-8 | Employee stock plan registration | Mar 9, 2020 | — |
| 10-K | Annual report | Mar 9, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2020 | Dec 31, 2019 |
| SEC STAFF LETTER | Filing | Feb 27, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 6, 2020 | — |
| 424B5 | Prospectus supplement | Jan 23, 2020 | — |
| 8-K |
Current report
Other events
|
Jan 23, 2020 | Jan 23, 2020 |
| 424B5 | Prospectus supplement | Jan 22, 2020 | — |
| 8-K |
Current report
Other events
|
Jan 13, 2020 | Jan 13, 2020 |
| 8-K |
Current report
Officer or director change
|
Jan 10, 2020 | Jan 8, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Dec 2, 2019 | Dec 2, 2019 |
| 424B5 | Prospectus supplement | Nov 5, 2019 | — |
| 8-K |
Current report
Material agreement
|
Nov 5, 2019 | Nov 5, 2019 |
| 10-Q | Quarterly report | Nov 5, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2019 | Nov 5, 2019 |
| S-8 | Employee stock plan registration | Sep 13, 2019 | — |
| CT ORDER | Filing | Sep 11, 2019 | — |
| CT ORDER | Filing | Sep 11, 2019 | — |
| 8-K |
Current report
Other events
|
Sep 10, 2019 | Sep 4, 2019 |
| EFFECT | Filing | Aug 15, 2019 | — |
| CORRESP | Letter to the SEC | Aug 13, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 12, 2019 | — |
| S-3 | Shelf registration | Aug 6, 2019 | — |
| 10-Q | Quarterly report | Aug 6, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2019 | Aug 6, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2019 | Jun 4, 2019 |
| 10-Q | Quarterly report | May 7, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Results of operations
|
May 7, 2019 | May 7, 2019 |
| DEF 14A | Proxy statement | Apr 29, 2019 | Jun 3, 2019 |
| 8-K |
Current report
Officer or director change
|
Mar 25, 2019 | Mar 19, 2019 |
| 8-K |
Current report
Other events
|
Mar 13, 2019 | Mar 13, 2019 |
| S-8 | Employee stock plan registration | Mar 6, 2019 | — |
| 10-K | Annual report | Mar 6, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2019 | Mar 6, 2019 |
| CT ORDER | Filing | Dec 17, 2018 | — |
| 10-Q | Quarterly report | Nov 6, 2018 | Sep 30, 2018 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2018 | Nov 6, 2018 |
| 424B5 | Prospectus supplement | Sep 13, 2018 | — |
| 8-K |
Current report
Agreement ended, Unregistered share sale, Other events
|
Sep 13, 2018 | Sep 13, 2018 |
| 424B5 | Prospectus supplement | Sep 12, 2018 | — |
| 8-K |
Current report
Other events
|
Sep 12, 2018 | Sep 12, 2018 |
| CT ORDER | Filing | Sep 11, 2018 | — |
| 8-K |
Current report
Material agreement, Other events
|
Sep 11, 2018 | Sep 7, 2018 |
| 8-K |
Current report
Results of operations, Other events
|
Sep 6, 2018 | Sep 6, 2018 |
| 8-K |
Current report
Other events
|
Aug 29, 2018 | Aug 29, 2018 |
| 10-Q | Quarterly report | Aug 7, 2018 | Jun 30, 2018 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- XENE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Burnaby
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1582313
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.